<unk> , sold under the brand name Livmarli, is a medication used to treat cholestatic pruritus in people with Alagille syndrome.<unk>  is an ileal bile acid transporter (IBAT) inhibitor.<unk>  was approved for medical use in the United States in September 2021.
Maralixibat chloride
Dimethyllysergamide
Propylpyrazoletriol
Ketotifen
Epiestriol
Gestonorone caproate
Ladostigil
Eluxadoline